Aurinia Pharmaceuticals (AUPH) Announces Board Restructuring

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. FIX
9. TSCO
10. BE

Go back to Aurinia Pharmaceuticals (AUPH) Announces Board Restructuring

Aurinia Announces Board Restructuring

September 12, 2024 4:05 PM EDT

Peter Greenleaf, President and Chief Executive Officer of Aurinia, remains a Director Kevin Tang, President of Tang Capital Management, LLC, appointed as a Director The Board has accepted the conditional resignations of three directors who received less than majority support at the 2024 Annual General Meeting

ROCKVILLE, Md. & EDMONTON, Alberta--(BUSINESS WIRE)-- Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that it has restructured its Board of Directors (the Board) to further align the Company with shareholder interests.

Peter Greenleaf, President... More